Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01993186 |
|---|---|
| Brief Title: | Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) |
| First Submitted : | October 31, 2013 |
| First Submitted that Met QC Criteria : | November 18, 2013 |
| First Posted : | November 25, 2013 (Estimate) |
| Results First Submitted : | May 12, 2020 |
| Results First Submitted that Met QC Criteria : | May 12, 2020 |
| Results First Posted : | May 29, 2020 |
| Certification/Extension First Submitted : | August 21, 2018 |
| Certification/Extension First Submitted that Met QC Criteria : | August 23, 2018 |
| Certification/Extension First Posted : | August 28, 2018 |
| Last Update Submitted that Met QC Criteria : | June 8, 2020 |
| Last Update Posted : | June 19, 2020 |